title: Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
abstract: Linear and nonlinear quantitative structure activity relationship models for predicting the inhibitory activities of sulfonamides toward different carbonic anhydrase isozymes were developed based on multilinear regression, principal component-artificial neural network and correlation ranking-principal component analysis, to identify a set of structurally based numerical descriptors. Multilinear regression was used to build linear quantitative structure activity relationship models using 53 compounds with their quantum chemical descriptors. For each type of isozyme, separate quantitative structure activity relationship models were obtained. It was found that the hydration energy plays a significant role in the binding of ligands to the CAI isozyme, whereas the presence of five-membered ring was detected as a major factor for the binding to the CAII isozyme. It was also found that the softness exhibited significant effect on the binding to CAIV isozyme. Principal component-artificial neural network and correlation ranking-principal component analysis analyses provide models with better prediction capability for the three types of the carbonic anhydrase isozyme inhibitory activity than those obtained by multilinear regression analysis. The best models, with improved prediction capability, were obtained for the hCAII isozyme activity. Models predictivity was evaluated by cross-validation, using an external test set and chance correlation test.
authors.affiliation: Faculty of Pharmacy, Al-Quds University, P.O. Box 20002 Jerusalem, Palestine. deeb2000il@yahoo.com
authors.forename: Omar
authors.initials: O
authors.lastname: Deeb
authors.forename: Mohammad
authors.initials: M
authors.lastname: Goodarzi
authors.forename: Padmaker V
authors.initials: PV
authors.lastname: Khadikar
mesh_terms: D000818:Animals; D024401:Carbonic Anhydrase I / Q000037:antagonists & inhibitors* / Q000378:metabolism; D024402:Carbonic Anhydrase II / Q000037:antagonists & inhibitors* / Q000378:metabolism; D030741:Carbonic Anhydrase IV / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002257:Carbonic Anhydrase Inhibitors / Q000737:chemistry* / Q000494:pharmacology*; D002417:Cattle; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism; D008954:Models, Biological; D016571:Neural Networks, Computer; D025341:Principal Component Analysis; D021281:Quantitative Structure-Activity Relationship; D013449:Sulfonamides / Q000737:chemistry* / Q000494:pharmacology*
chemical_list: D002257:Carbonic Anhydrase Inhibitors; D007527:Isoenzymes; D013449:Sulfonamides; D024401:Carbonic Anhydrase I; D024402:Carbonic Anhydrase II; D030741:Carbonic Anhydrase IV